- Home
- IOVA vs HSTM Comparison
IOVA vs HSTM Comparison
Compare IOVA & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- HSTM
- Stock Information
- Founded
- IOVA 2007
- HSTM 1990
- Country
- IOVA United States
- HSTM United States
- Employees
- IOVA N/A
- HSTM N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- HSTM Computer Software: Programming Data Processing
- Sector
- IOVA Health Care
- HSTM Technology
- Exchange
- IOVA Nasdaq
- HSTM Nasdaq
- Market Cap
- IOVA 975.1M
- HSTM 828.5M
- IPO Year
- IOVA N/A
- HSTM 2000
- Fundamental
- Price
- IOVA $2.69
- HSTM $27.74
- Analyst Decision
- IOVA Buy
- HSTM Hold
- Analyst Count
- IOVA 11
- HSTM 2
- Target Price
- IOVA $11.90
- HSTM $28.00
- AVG Volume (30 Days)
- IOVA 16.7M
- HSTM 185.5K
- Earning Date
- IOVA 08-07-2025
- HSTM 10-20-2025
- Dividend Yield
- IOVA N/A
- HSTM 0.45%
- EPS Growth
- IOVA N/A
- HSTM 14.03
- EPS
- IOVA N/A
- HSTM 0.67
- Revenue
- IOVA $241,525,000.00
- HSTM $295,211,000.00
- Revenue This Year
- IOVA $86.62
- HSTM $4.90
- Revenue Next Year
- IOVA $69.13
- HSTM $5.12
- P/E Ratio
- IOVA N/A
- HSTM $41.13
- Revenue Growth
- IOVA 636.99
- HSTM 3.50
- 52 Week Low
- IOVA $1.64
- HSTM $25.36
- 52 Week High
- IOVA $12.51
- HSTM $34.24
- Technical
- Relative Strength Index (RSI)
- IOVA 54.92
- HSTM 63.11
- Support Level
- IOVA $2.44
- HSTM $26.28
- Resistance Level
- IOVA $2.85
- HSTM $26.83
- Average True Range (ATR)
- IOVA 0.24
- HSTM 0.59
- MACD
- IOVA -0.00
- HSTM 0.19
- Stochastic Oscillator
- IOVA 83.16
- HSTM 98.65
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.